BRAF V600E-mutant Metastatic Colorectal Cancer
2 competing products in clinical development for BRAF V600E-mutant Metastatic Colorectal Cancer.
Pipeline by Phase
Phase 21
Phase 31
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Encorafenib + Binimetinib + Cetuximab + Irinotecan + Folinic Acid + 5-Fluorouracil | Ono Pharmaceutical | Phase 3 | Completed | 40 |
| encorafenib + Binimetinib + Cetuximab | Ono Pharmaceutical | Phase 2 | Completed | 35 |